PROGNOSTIC FACTORS IN NODE-NEGATIVE BREAST-CANCER

被引：0
|
作者：
JOHNSON, H
MASOOD, S
BELLUCO, C
ABOUAZAMA, AM
DEE, S
KAHN, L
WISE, L
机构：
[1] UNIV FLORIDA HOSP,HLTH SCI CTR,DEPT PATHOL,JACKSONVILLE,FL
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[3] LONG ISL JEWISH MED CTR,DEPT PATHOL,NEW HYDE PK,NY 11042
来源：
ARCHIVES OF SURGERY | 1992年 / 127卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
One hundred patients with node-negative breast cancer were examined to analyze the influence of tumor size, nuclear grade, and DNA content determined by flow cytometry on overall survival. Patients with diploid cancers lived significantly longer than those with aneuploid cancers (126 +/- 8 vs 80 +/- 11 months). Patients with an S-phase fraction less than 10% lived significantly longer than those with S-phase fractions 10% or greater (122 +/- 8 vs 85 +/- 10 months). Tumor size had the major impact on survival, and multivariate analysis of variance by the Cox proportional hazards model showed the greatest effect on prognosis. Tumor grade did not significantly influence overall survival.
引用
收藏
页码：1386 / 1391
页数：6
相关论文
共 50 条
  • [31] NODE-NEGATIVE BREAST-CANCER AND THE CLINICAL ALERT
    DORR, FA
    FRIEDMAN, MA
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (07) : 622 - 622
  • [32] ADJUVANT CHEMOTHERAPY FOR NODE-NEGATIVE BREAST-CANCER
    SLEDGE, GW
    MCCASKILLSTEVENS, W
    CANCER INVESTIGATION, 1992, 10 (06) : 595 - 602
  • [33] ADJUVANT THERAPY FOR NODE-NEGATIVE BREAST-CANCER
    DONOHUE, JH
    NAGORNEY, DM
    GRANT, CS
    VANHEERDEN, JA
    SARR, MG
    STERIOFF, S
    FARNELL, MB
    MCILRATH, DC
    PEMBERTON, JH
    MUCHA, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07): : 470 - 470
  • [34] ADJUVANT THERAPY OF NODE-NEGATIVE BREAST-CANCER
    HALL, PD
    LESHER, BA
    HALL, RK
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (03) : 289 - 298
  • [35] THE ROLE OF CHEMOTHERAPY FOR NODE-NEGATIVE BREAST-CANCER
    COOPER, MR
    CANCER, 1991, 67 (06) : 1744 - 1747
  • [36] NCI ALERT ON NODE-NEGATIVE BREAST-CANCER
    不详
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 3 - 5
  • [37] NODE-NEGATIVE BREAST-CANCER - TAMOXIFEN AND CHEMOSUPPRESSION
    JORDAN, VC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) : 1068 - 1069
  • [38] FACTORS PREDICTING TREATMENT RESPONSIVENESS AND PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER
    NEVILLE, AM
    BETTELHEIM, R
    GELBER, RD
    SAVESODERBERGH, J
    DAVIS, BW
    REED, R
    TORHORST, J
    GOLOUH, R
    PETERSON, HF
    PRICE, KN
    ISLEY, M
    RUDENSTAM, CM
    COLLINS, J
    CASTIGLIONE, M
    SENN, HJ
    GOLDHIRSCH, A
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 696 - 705
  • [39] Prognostic factors affecting the natural history of node-negative breast cancer
    Maureen E. Trudeau
    Kathleen I. Pritchard
    Judy-Anne W. Chapman
    Wedad M. Hanna
    Harriette J. Kahn
    David Murray
    Carol A. Sawka
    Betty G. Mobbs
    Irene Andrulis
    David R. McCready
    H. Lavina Lickley
    Breast Cancer Research and Treatment, 2005, 89 : 35 - 45
  • [40] Clinical relevance of prognostic factors in axillary node-negative breast cancer
    Thomssen, C
    Jänicke, F
    Harbeck, N
    ONKOLOGIE, 2003, 26 (05): : 438 - 445
12345